19 results on '"Oviedo, Pilar"'
Search Results
2. Raloxifene promotes prostacyclin release in human endothelial cells through a mechanism that involves cyclooxygenase-1 and -2
- Author
-
Oviedo, Pilar J., Hermenegildo, Carlos, Tarín, Juan J., and Cano, Antonio
- Published
- 2005
- Full Text
- View/download PDF
3. Assessment of Antimicrobial and Pesticide Residues in Food Products Sourced from Peasant Family Farming in Chile.
- Author
-
LAPIERRE, LISETTE, QUINTREL, MARIANELA, LAGOS-SUSAETA, FRANCISCO, HERVÉ-CLAUDE, LUIS PABLO, RIQUELME, RICARDO, OVIEDO, PILAR, MAINO, MARIO, and CORNEJO, JAVIERA
- Subjects
PESTICIDE residues in food ,FAMILY farms ,ANIMAL products ,PEASANTS ,ANTI-infective agents - Abstract
The presence of antimicrobial and pesticide residues in products sourced from peasant family farms selected from eight regions of Chile was determined. A total of 204 samples were analyzed from family farm products, including honey, lettuce, tomato, strawberry, raspberry, lamb meat, and cow’s milk. Pesticide residues were found in 43 of 107 samples tested for them, but only 4 samples had concentrations that exceeded the maximum residue limits (MRLs) set by Chilean regulations. As for animal products, 2 of 15 cow’s milk samples tested positive for permethrin residues; however, these concentrations did not exceed Chilean MRLs. No pesticide residues were detected in honey samples. As for antimicrobial drugs, 4 of 14 lamb meat samples and 11 of 79 cow’s milk samples tested positive for different classes of antimicrobial residues, such as tetracyclines, macrolides, aminoglycosides, and β-lactams. Among these, only three samples exceeded the MRLs for these matrices. Traces of tetracyclines and sulfonamides were detected in 7 of 29 honey samples. These findings show that these chemical contaminants are present in trace concentrations in foodstuffs produced by peasant family farms in Chile; however, most residues did not exceed the regulatory limits. This study is the first assessment of the presence of residues from antimicrobial drugs and pesticides in food products sourced from peasant family farms in Chile. Data about the current state of drug residues in this segment of food products provide a baseline for efforts to close possible gaps in current surveillance schemes. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Salmonella enterica in pinnipeds, Chile
- Author
-
Sturm, Natalie, Abalos, Pedro, Fernandez, Alda, Rodriguez, Guillermo, Oviedo, Pilar, Arroyo, Viviana, and Retamal, Patricio
- Subjects
Medical research -- Health aspects ,Medicine, Experimental -- Health aspects ,Salmonella -- Health aspects ,Health - Abstract
To the Editor: Several wildlife-associated zoonotic agents have played a major role in the emergence of diseases in humans (1). However, diseases can also emerge in wildlife as a result [...]
- Published
- 2011
- Full Text
- View/download PDF
5. Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway
- Author
-
Oviedo, Pilar J., Sobrino, Agua, Laguna-Fernandez, Andrés, Novella, Susana, Tarín, Juan J., García-Pérez, Miguel-Angel, Sanchís, Juan, Cano, Antonio, and Hermenegildo, Carlos
- Subjects
- *
ESTRADIOL , *ENDOTHELIUM , *CELL migration , *CELL proliferation , *ESTROGEN receptors , *NEOVASCULARIZATION , *CARDIOVASCULAR system , *CELL cycle - Abstract
Abstract: Migration and proliferation of endothelial cells are involved in re-endothelialization and angiogenesis, two important cardiovascular processes that are increased in response to estrogens. RhoA, a small GTPase which controls multiple cellular processes, is involved in the control of cell migration and proliferation. Our aim was to study the role of RhoA on estradiol-induced migration and proliferation and its dependence on estrogen receptors activity. Human umbilical vein endothelial cells were stimulated with estradiol, in the presence or absence of ICI 182780 (estrogen receptors antagonist) and Y-27632 (Rho kinase inhibitor). Estradiol increased Rho GEF-1 gene expression and RhoA (gene and protein expression and activity) in an estrogen receptor-dependent manner. Cell migration, stress fiber formation and cell proliferation were increased in response to estradiol and were also dependent on the estrogen receptors and RhoA activation. Estradiol decreased p27 levels, and significantly raised the expression of cyclins and CDK. These effects were counteracted by the use of either ICI 182780 or Y-27632. In conclusion, estradiol enhances the RhoA/ROCK pathway and increases cell cycle-related protein expression by acting through estrogen receptors. This results in an enhanced migration and proliferation of endothelial cells. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
6. Therapeutic dosages of oral or transdermal estradiol did not modify sCD40L levels in postmenopausal women.
- Author
-
Oviedo, Pilar J., Hermenegildo, Carlos, Sobrino, Agua, Tarín, Juan J., and Cano, Antonio
- Subjects
- *
ESTROGEN , *ESTRADIOL , *STEROLS , *ATHEROSCLEROTIC plaque , *ENZYME-linked immunosorbent assay - Abstract
The CD40/CD40L system is considered a crucial modulator of the inflammatory process underlying the progression and complication of atheroma plaques. The soluble fraction of CD40L (sCD40L) is a reliable indicator of the CD40/CD40L system. Our purpose was to investigate whether a therapeutic dose of estradiol, by either the oral or the transdermal route, was associated with changes in circulating levels of sCD40L. Forty-seven women completed a 4-week course of treatment with either oral estradiol valerate (2 mg/day, 20 women) or transdermal estradiol (50 μg/day, 27 women). Serum levels of sCD40L were measured by conventional enzyme-linked immunosorbent assay. Oral, but not transdermal estradiol, modified the lipid profile. Levels of sCD40L, however, remained unchanged compared with baseline. This neutral effect of oral or transdermal estradiol on sCD40L levels further advances our knowledge on the effects of estrogens on mechanisms involved in the progression and complication of atherosclerosis. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
7. Raloxifene ⁎ [⁎] Lilly Research Laboratories, Indianapolis, Indiana. increases proliferation of human endothelial cells in association with increased gene expression of cyclins A and B1
- Author
-
Oviedo, Pilar J., Hermenegildo, Carlos, Tarín, Juan J., and Cano, Antonio
- Subjects
- *
MEDICAL laboratories , *CLINICAL pathology , *HEALTH facilities , *CELL proliferation - Abstract
Objective: To examine the proliferative effect of of raloxifene on human umbilical-vein endothelial cells (HUVECs), and to investigate whether there is an associated increased expression of some key regulators of the cell cycle. Design: Cell culture for different incubation times. Setting: University research laboratory. Patient(s): Sources of HUVECs. Intervention(s): Measurement of cell proliferation, of protein levels of cyclin A, cyclin B1, cyclin D1, cyclin-dependent protein kinase (CDK) 2, CDK4, and p27Kip1, and of messenger RNA expression of cyclin A, cyclin B1, and p27Kip1. Main Outcome Measure(s): Cell proliferation was measured by the 3-(4.5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, the bromo-2′-deoxyuridine assay, and the sodium 3′-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis (4-methoxy-6-nitro) benzene sulfonic acid hydrate assay. Changes in protein expression were measured by immunoblotting, and modifications in gene expression were measured by quantitative real-time polymerase chain reaction. Result(s): Both 1 nM and 10 nM of either E2 or raloxifene achieved a similar increase in cell proliferation. The pure antiestrogen ICI 182780 only blocked the E2-induced proliferative effect. Western blot experiments detected an increase in the expression of only cyclin A and B1, and a decreasing trend for p27Kip1. Enhancements in gene expression were observed in response to E2 and raloxifene for cyclin A and B1. No significant changes were found for p27Kip1. The ICI 182780 effectively abrogated the increased gene expression associated with E2 for cyclin B1, but not for cyclin A. In contrast, ICI 182780 was ineffective in the case of raloxifene. Conclusion(s): Raloxifene increased the proliferation of HUVECs in association with enhanced gene expression of cyclins A and B1. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
8. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells
- Author
-
Monsalve, Elena, Oviedo, Pilar J., García-Pérez, Miguel Angel, Tarín, Juan J., Cano, Antonio, and Hermenegildo, Carlos
- Subjects
- *
STEROLS , *ESTROGEN , *ESTRADIOL , *MESSENGER RNA - Abstract
Abstract: Objective: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, is a novel cardiovascular risk factor produced by endothelial cells. ADMA levels are mainly regulated by the activity of dimethylarginine dimethylaminohydrolases (DDAH). Endothelial release of ADMA is increased in the presence of oxidized LDL cholesterol (oxLDL), whereas estrogens stimulate NO production by endothelial cells by increasing both expression and activity of NO synthase and by reducing ADMA levels. Thus, the aim of the present study was to evaluate the estradiol effects on the DDAH/ADMA/NO pathway in cultured human umbilical vein endothelial cells (HUVEC) exposed to LDL. Methods: After 24 h of exposure to various treatments, culture medium was collected to measure NO production by using an amperometric sensor specific for NO, and to measure dimethylarginines by high-performance liquid chromatography (HPLC). DDAH-I and II mRNA expression and protein content were quantified by real-time PCR assay and immunoblotting, respectively. Results: Exposure of HUVEC to 100 μg/mL oxLDL, but not to 100 μg/mL of native LDL (nLDL), reduced DDAH-II expression at both the mRNA as well as the protein levels, which in turn increased ADMA levels and reduced NO production. Estradiol (1 nM) alone increased DDAH-II mRNA and protein expression, which reduced ADMA levels and increased NO production. In cells exposed to estradiol in combination with either nLDL or oxLDL, levels of DDAH-II, ADMA, and NO were the same as those for estradiol alone. Conclusion: Estradiol completely reverses the effects induced by oxLDL on the DDAH/ADMA/NO pathway. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
9. Therapeutic dosages of raloxifene do not modify myeloperoxidase and F2α-isoprostane levels in postmenopausal women
- Author
-
Oviedo, Pilar J., Hermenegildo, Carlos, Tarín, Juan J., and Cano, Antonio
- Subjects
- *
RALOXIFENE , *CORONARY disease , *DRUG monitoring , *STEROID hormones - Abstract
We investigated the effect of a therapeutic dose of raloxifene on the plasma levels of myeloperoxidase and F2α-isoprostanes, two markers of oxidative stress recently described as reliable indicators of coronary heart disease. Contrary to changes described in the literature for estrogens (E), raloxifene did not modify the levels of either myeloproxidase or F2α-isoprostanes after 3 or 6 months of treatment. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
10. Raloxifene increases the capacity of serum to promote prostacyclin release in human endothelial cells: implication of COX-1 and COX-2.
- Author
-
Oviedo PJ, Hermenegildo C, Cano A, Oviedo, Pilar J, Hermenegildo, Carlos, and Cano, Antonio
- Published
- 2004
- Full Text
- View/download PDF
11. Are the serum levels of sCD40L modified by raloxifene in postmenopausal women?
- Author
-
Oviedo, Pilar J., Hermenegildo, Carlos, Novella, Susana, Tarín, Juan J., and Cano, Antonio
- Published
- 2008
- Full Text
- View/download PDF
12. The Adoption of Good Practices for Pesticides and Veterinary Drugs Use among Peasant Family Farmers of Chile.
- Author
-
Lagos Susaeta, Francisco, Maino, Mario, Riquelme, Ricardo, Baeza Villarroel, Andrea, Quintrel, Marianela, Lapierre, Lisette, Oviedo, Pilar, Cornejo, Javiera, and Hervé-Claude, Luis Pablo
- Subjects
PEASANTS ,PESTICIDES ,VETERINARY drugs ,FOOD toxicology ,CLIMATE change - Abstract
Improvements and good practices (GPs) in rural environments are often developed by peasants themselves and shared among trust-based networks. The level of adoption of GPs by peasant family farmers (PFF) has been poorly studied. This paper describes the performance and results of the innovation adoption index (InAI) and rate (InAR) which were used to estimate the adoption of GPs for pesticide and veterinary drug use by PFF from eight different regions of Chile. Surveys were conducted among 257 farmers to find out about the adoption (yes/no) of a set of GPs in the adequate handling, use and storage of these chemical products, as well as some identifying information. The farmers in this study are producers of berries, dairy cows, honey and vegetables. The results of the survey showed an average of 57.33% GPs were adopted by farmers. Group averages of 55.23–61.32% were observed in the numbers of practices adopted by farmers. This survey data collection was part of a wider study intended to design a national plan to reduce chemical residues in food produced by PFF in Chile, with a focus on organizing practical workshops with extension officers and farmers. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
13. Estradiol Stimulates Vasodilatory and Metabolic Pathways in Cultured Human Endothelial Cells.
- Author
-
Sobrino, Agua, Mata, Manuel, Laguna-Fernandez, Andrés, Novella, Susana, Oviedo, Pilar J., García-Pérez, Miguel Angel, Tarín, Juan J., Cano, Antonio, and Hermenegildo, Carlos
- Abstract
Vascular effects of estradiol are being investigated because there are controversies among clinical and experimental studies. DNA microarrays were used to investigate global gene expression patterns in cultured human umbilical vein endothelial cells (HUVEC) exposed to 1 nmol/L estradiol for 24 hours. When compared to control, 187 genes were identified as differentially expressed with 1.9-fold change threshold. Supervised principal component analysis and hierarchical cluster analysis revealed the differences between control and estradiol-treated samples. Physiological concentrations of estradiol are sufficient to elicit significant changes in HUVEC gene expression. Notch signaling, actin cytoskeleton signaling, pentose phosphate pathway, axonal guidance signaling and integrin signaling were the top-five canonical pathways significantly regulated by estrogen. A total of 26 regulatory networks were identified as estrogen responsive. Microarray data were confirmed by quantitative RT-PCR in cardiovascular meaning genes; cyclooxigenase (COX)1, dimethylarginine dimethylaminohydrolase (DDAH)2, phospholipase A2 group IV (PLA2G4) B, and 7-dehydrocholesterol reductase were upregulated by estradiol in a dose-dependent and estrogen receptor-dependent way, whereas COX2, DDAH1 and PLA2G4A remained unaltered. Moreover, estradiol-induced COX1 gene expression resulted in increased COX1 protein content and enhanced prostacyclin production. DDAH2 protein content was also increased, which in turn decreased asymmetric dimethylarginine concentration and increased NO release. All stimulated effects of estradiol on gene and protein expression were estrogen receptor-dependent, since were abolished in the presence of the estrogen receptor antagonist ICI 182780. This study identifies new vascular mechanisms of action by which estradiol may contribute to a wide range of biological processes. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
14. Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{alpha}.
- Author
-
Sobrino A, Oviedo PJ, Novella S, Laguna-Fernandez A, Bueno C, García-Pérez MA, Tarín JJ, Cano A, and Hermenegildo C
- Subjects
- Cells, Cultured, Cyclooxygenase 1 genetics, Cyclooxygenase 1 metabolism, Cytochrome P-450 Enzyme System genetics, Cytochrome P-450 Enzyme System metabolism, Endothelial Cells cytology, Endothelium, Vascular cytology, Epoprostenol genetics, Estrogen Receptor alpha genetics, Estrogen Receptor beta genetics, Estrogen Receptor beta metabolism, Female, Group IV Phospholipases A2 genetics, Group IV Phospholipases A2 metabolism, Humans, Intramolecular Oxidoreductases genetics, Intramolecular Oxidoreductases metabolism, Male, Thromboxane A2 metabolism, Endothelial Cells metabolism, Endothelium, Vascular metabolism, Epoprostenol biosynthesis, Estradiol metabolism, Estrogen Receptor alpha metabolism
- Abstract
Estradiol (E(2)) acts on the endothelium to promote vasodilatation through the release of several compounds, including prostanoids, which are products of arachidonic acid metabolism. Among these, prostacyclin (PGI2) and thromboxane A2 (TXA2) exert opposite effects on vascular tone. The role of different estrogen receptors (ERs) in the PGI2/TXA2 balance, however, has not been fully elucidated. Our study sought to uncover whether E(2) enhances basal production of PGI2 or TXA2 in cultured human umbilical vein endothelial cells (HUVECs), to analyze the enzymatic mechanisms involved, and to evaluate the different roles of both types of ERs (ERalpha and ERbeta). HUVECs were exposed to E(2), selective ERalpha (1,3,5-tris(4-hydroxyphenyl)-4-propyl-1h-pyrazole, PPT) or ERbeta (diarylpropionitrile, DPN) agonists and antagonists (unspecific: ICI 182 780; specific for ERalpha: methyl-piperidino-pyrazole, MPP). PGI2 and TXA2 production was measured by ELISA. Expression of phospholipases, cyclooxygenases (COX-1 and COX-2), PGI2 synthase (PGIS), and thromboxane synthase (TXAS) was analyzed by western blot and quantitative RT-PCR. E(2) (1-100 nM) dose dependently increased PGI2 production (up to 50%), without affecting TXA2 production. COX-1 and PGIS protein and gene expressions were increased, whereas COX-2, phospholipases, and TXAS expression remained unaltered. All these effects were mediated through ERalpha, since they were produced not only in the presence of E(2), but also in that of PPT, while they were abolished in the presence of MPP. In conclusion, E(2), acting through ERalpha, up-regulates COX-1 and PGIS expression, thus directing prostanoid balance toward increased PGI2 production.
- Published
- 2010
- Full Text
- View/download PDF
15. Transdermal estradiol reduces F2alpha-isoprostane levels in postmenopausal women.
- Author
-
Hermenegildo C, Oviedo PJ, Laguna A, García-Pérez MA, Tarín JJ, and Cano A
- Subjects
- Administration, Cutaneous, Administration, Oral, Cholesterol blood, Female, Humans, Lipoproteins blood, Medroxyprogesterone administration & dosage, Middle Aged, Progestins administration & dosage, Estradiol administration & dosage, Estrogen Replacement Therapy, F2-Isoprostanes blood, Postmenopause blood
- Abstract
Objective: F2alpha-isoprostanes are considered the most reliable index of in vivo oxidative stress. Given the implication of oxidative stress in the pathogenesis of atherosclerosis, we investigated the effects of hormone therapy on the plasma levels of F2alpha-isoprostanes., Design: Sixty-one healthy postmenopausal women were treated in a randomized trial with estradiol either orally (2 mg/day, 28 women) or transdermally (50 mug/day, 33 women) for 4 weeks. Then women in each group were randomly assigned to oral progestogen, either micronized progesterone (300 mg/day) or medroxyprogesterone acetate (5 mg/day) for 2 additional weeks. Plasma samples were collected before and at the end of each treatment period, either estradiol alone or estradiol plus progestogen. F2alpha-isoprostanes were measured by a commercial enzyme immunoassay., Results: A significant reduction in the levels of F2alpha-isoprostanes was detected only in women receiving transdermal estradiol, alone or in combination with medroxyprogesterone acetate., Conclusions: Transdermal estradiol alone or associated with medroxyprogesterone acetate decreased plasma levels of F2alpha-isoprostanes. These data elucidate additional details of the beneficial effect of estradiol on oxidative stress, a relevant mechanism in atherogenesis.
- Published
- 2008
- Full Text
- View/download PDF
16. The risk for cardiovascular disease in women: from estrogens to selective estrogen receptor modulators.
- Author
-
Cano A, Hermenegildo C, Oviedo P, and Tarín JJ
- Subjects
- Animals, Cardiovascular Diseases etiology, Cardiovascular Diseases prevention & control, Coronary Disease etiology, Estrogens adverse effects, Estrogens therapeutic use, Female, Humans, Rats, Risk Factors, Selective Estrogen Receptor Modulators adverse effects, Selective Estrogen Receptor Modulators therapeutic use, Sex Factors, Stroke epidemiology, Thromboembolism epidemiology, Venous Thrombosis epidemiology, Women's Health, Cardiovascular Diseases epidemiology, Estrogens pharmacology, Selective Estrogen Receptor Modulators pharmacology
- Abstract
Cardiovascular disease, a generic denomination including coronary heart disease (CHD), stroke, and venous thromboembolic disease (VTED), has shown sensitivity to estrogens. The relative protection of women as compared with men has nourished a debate about a possible protective role for estrogens, but the prejudicial effects detected in clinical trials has created confusion on the risk/benefit ratio induced by hormone administration. The hypothesis that agonists distinct to estrogens might improve the effects associated with estrogens is at the base of the increasing interest on the role of selective estrogen receptor modulators (SERMs). There is a lack of definitive clearcut clinical data on the effects of SERMs in CVD, although the available information suggests a neutral balance on CHD and stroke and an increase in risk similar to estrogens for VTED. Research on pathogenetic mechanisms concentrates in atherosclerosis as the main determinant of the arterial forms of the disease and in hypercoagulability as the counterpart for venous disease. The different experimental models used up to the present moment suggest that, compared with estrogens, SERMs play a less active protection against atherogenesis but do not increase vulnerability of unstable plaques. There is not a clear notion on the mechanisms promoted by SERMs to increase risk for VTED.
- Published
- 2007
- Full Text
- View/download PDF
17. Therapeutic dosages of raloxifene do not modify myeloperoxidase and F2alpha-isoprostane levels in postmenopausal women.
- Author
-
Oviedo PJ, Hermenegildo C, Tarín JJ, and Cano A
- Subjects
- Antioxidants administration & dosage, Biomarkers blood, Cardiovascular Diseases metabolism, Female, Humans, Middle Aged, Neutrophils metabolism, Oxidative Stress drug effects, Postmenopause, Cardiovascular Diseases prevention & control, F2-Isoprostanes blood, Peroxidase blood, Raloxifene Hydrochloride administration & dosage, Selective Estrogen Receptor Modulators administration & dosage
- Abstract
We investigated the effect of a therapeutic dose of raloxifene on the plasma levels of myeloperoxidase and F2alpha-isoprostanes, two markers of oxidative stress recently described as reliable indicators of coronary heart disease. Contrary to changes described in the literature for estrogens (E), raloxifene did not modify the levels of either myeloproxidase or F2alpha-isoprostanes after 3 or 6 months of treatment.
- Published
- 2005
- Full Text
- View/download PDF
18. Effects of phytoestrogens genistein and daidzein on prostacyclin production by human endothelial cells.
- Author
-
Hermenegildo C, Oviedo PJ, García-Pérez MA, Tarín JJ, and Cano A
- Subjects
- Cell Survival drug effects, Cyclooxygenase 1 biosynthesis, Cyclooxygenase 2 biosynthesis, Cyclooxygenase 2 Inhibitors pharmacology, Endothelial Cells drug effects, Female, Humans, Immunoblotting, Infant, Newborn, Male, Protein-Tyrosine Kinases antagonists & inhibitors, RNA, Messenger biosynthesis, RNA, Messenger isolation & purification, Receptors, Estrogen drug effects, Reverse Transcriptase Polymerase Chain Reaction, Endothelial Cells metabolism, Epoprostenol biosynthesis, Estrogens, Non-Steroidal pharmacology, Genistein pharmacology, Isoflavones pharmacology, Phytoestrogens pharmacology
- Abstract
The molecular mechanisms of the vascular effects of phytoestrogens are poorly studied. Prostacyclin is a potent vasodilator synthesized by two isoforms of cyclooxygenase (COX) in endothelium. This study examine the effects of two phytoestrogens, the isoflavones genistein and daidzein, on prostacyclin production by cultured human umbilical vein endothelial cells (HUVECs) and the possible role of not only estrogen receptors but also both COX isoforms. The two phytoestrogens significantly increased prostacyclin release in a time- and dose-dependent (0.01-1 microM) manner, being higher than control after 24 h. Selective inhibitors of COX-1, SC-560 [5-(4-chlorophenyl)-1-(4-methoxypjenyl)-3-(trifluoromethyl)-1H-pyrazole], and COX-2, NS-398 (N-[2-(cyclohexyloxy)-4 nitrophenyl]-methanesulfonamide), were used to investigate the relative contribution of each enzyme. Both inhibitors decreased basal production of prostacyclin, but only COX-2 inhibition completely abolished the isoflavone-stimulated prostacyclin production. Phytoestrogens also increased COX-2 mRNA expression and protein content without affecting COX-1 levels. All these effects were mediated through estrogen receptor activation since treatment of cells with the estrogen receptor antagonist ICI 182780 [7alpha-[9[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17beta diol] completely abolished the isoflavone-induced increase in prostacyclin production, COX-2 mRNA expression, and COX-2 protein content. The results clearly support the hypothesis that genistein and daidzein increased HUVEC prostacyclin production through estrogen receptor-dependent mechanism, which involved the enhancement of COX-2 protein and activity.
- Published
- 2005
- Full Text
- View/download PDF
19. Cooling Raw Milk: Change in the Spoilage Potential of Contaminating Pseudomonas.
- Author
-
Jaspe A, Oviedo P, Fernandez L, Palacios P, and Sanjose C
- Abstract
A group of 80 Pseudomonas spp. strains isolated from raw milk shortly after milking was compared to another group of 81 obtained from the same sample after incubating it at 7°C for 3 days. Comparison of both collections of strains included growth rates at 7°C and 21°C and production of extracellular proteinase, lipase, and siderophores. The strains selected after cold incubation showed an average to-fold higher growth rate at 7°C, 1,000-fold more proteolytic activity, and 280-fold more lipolytic activity than those found before the incubation. At 21°C, however, they grew half as quickly as the strains isolated before the incubation. In all but one of the 161 Pseudomonas strains tested, there was some production of siderophores, and yields were only moderately increased in the strains obtained after incubation of the milk at 7°C. These changes in spoilage-related properties took place while global Pseudomonas counts increased only 13-fold. Distribution frequencies of the variables tested, their correlation coefficients, and regression models are shown.
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.